.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Julphar
Healthtrust
McKesson
Argus Health
UBS
Deloitte
Fuji
Express Scripts
Fish and Richardson

Generated: November 17, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Acid-addition salts of optically active piperidine compound and process for producing the same
Abstract:The present invention is to provide a benzenesulfonic acid salt and a benzoic acid salt of (S)-4-[4-[(4-chlorophenyl) (2-pyridyl)methoxy]piperidino]butanoic acid represented by the formula (I): ##STR1## wherein * represents an asymmetric carbon, which are excellent in antihistaminic activity and anti-allergic activity, and a process for producing the same.
Inventor(s): Kita; Jun-ichiro (Ube, JP), Fujiwara; Hiroshi (Ube, JP), Takamura; Shinji (Ube, JP), Yoshioka; Ryuzo (Osaka, JP), Ozaki; Yasuhiko (Osaka, JP), Yamada; Shin-ichi (Takarazuka, JP)
Assignee: Ube Industries, Ltd. (Yamaguchi, JP) Tanabe Seiyaku Co., Ltd. (Osaka, JP)
Filing Date:Jun 25, 1999
Application Number:09/331,792
Claims:1. A process for preparing a benzenesulfonic acid salt or a benzoic acid salt of the optically active piperidine compound represented by formula (I) ##STR13##

which comprises reacting (.+-.)-4-[(4-chlorophenyl)(2-pyridyl)methoxy]-piperidine with an optically active propionic acid compound represented by the formula (VII): ##STR14##

wherein Y represents a hydrogen atom or a halogen atom; Z represents a lower alkoxy group; and * represents an asymmetric carbon, or an optically active N-acyl-amino acid; separating and collecting a less soluble diastereomeric salt by utilizing the difference in solubilities of the formed two kinds of diastereomeric salts; decomposing the resulting salt; reacting the resulting (S)-4-[4-chlorophenyl)(2- pyridyl)methoxy]piperidine with an ester represented by the formula (V): ##STR15##

wherein R represents a lower alkyl group, and W represents a leaving group such as a halogen atom and a reactive ester group,

to obtain (S)-4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino] butanoic acid ester represented by the formula (VI): ##STR16##

wherein R and * have the same meaning as defined above; hydrolyzing the resulting compound; and reacting the hydrolyzed compound with benzenesulfonic acid or benzoic acid to form a salt.

2. A process for preparing an optically active piperidine intermediate represented by the formula (IV): ##STR17##

wherein * represents an asymmetric carbon, which comprises reacting a racemic piperidine compound represented by the formula (III): ##STR18##

with an optically active propionic acid compound represented by the formula (VII): ##STR19##

wherein Y represents a hydrogen atom or a halogen atom;

Z represents a lower alkoxy group; and * has the same meanings as defined above,

or an optically active N-acyl-amino acid; separating and collecting one of the diastereomeric salts by utilizing the difference in solubilities of the formed two kinds of diastereomeric salts; and decomposing the resulting salt.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Novartis
Queensland Health
Cerilliant
Johnson and Johnson
QuintilesIMS
Harvard Business School
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot